- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04445168
Randomized Trial of Exercise Promotion in Primary Care (EPPC)
Intervention Based in Primary Care to Increase Physical Activity Among Inactive Adults With Prediabetes and Diabetes
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Pasadena, California, United States, 911010
- Kaiser Permanente Southern California
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Able to speak English or Spanish, Inactive defined as less than 30 minutes of MVPA per week, Prediabetes or diabetes not prescribed insulin, Kaiser Permanente member for at least 12 months, Receives primary care at the Fontana Medical Center, Body mass index between 18.5 and 40 kg/m2,
Exclusion Criteria:
Current use of insulin, Cardiovascular event in the past 6 months or other condition that limits physical activity, Pregnancy, breastfeeding or planning pregnancy in next 2 years, Current participation in another clinical trial or research study, Plans to move out of the area in next 2 years,
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual Care
Participants assigned to usual care may receive advice from their primary care physician to increase their physical activity.
They will receive handouts about every 6 weeks on general health topics.
|
|
|
Experimental: Intervention
Participants assigned to the intervention arm will receive telephone-based motivational interviews with trained interventionists to encourage increases in physical activity.
|
2-year telephone-based motivational interviews to increase physical activity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Moderate to vigorous physical activity (MVPA)
Time Frame: 12 months
|
Accelerometer-derived 7-day MVPA
|
12 months
|
|
Moderate to vigorous physical activity (MVPA)
Time Frame: 24 months
|
Accelerometer-derived 7-day MVPA
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: 12 months
|
Weight assessed from electronic medical records
|
12 months
|
|
Weight
Time Frame: 24 months
|
Weight assessed from electronic medical records
|
24 months
|
|
Systolic blood pressure
Time Frame: 12 months
|
Systolic blood pressure assessed from electronic medical records
|
12 months
|
|
Systolic blood pressure
Time Frame: 24 months
|
Systolic blood pressure assessed from electronic medical records
|
24 months
|
|
Diastolic blood pressure
Time Frame: 12 months
|
Diastolic blood pressure assessed from electronic medical records
|
12 months
|
|
Diastolic blood pressure
Time Frame: 24 months
|
Diastolic blood pressure assessed from electronic medical records
|
24 months
|
|
HbA1c
Time Frame: 12 months
|
HbA1c assessed from electronic medical records
|
12 months
|
|
HbA1c
Time Frame: 24 months
|
HbA1c assessed from electronic medical records
|
24 months
|
|
Health-related quality of life
Time Frame: 12 months
|
Assessed from the short form (SF-8) instrument; scale 0 - 100, higher is more favorable quality of life
|
12 months
|
|
Health-related quality of life
Time Frame: 24 months
|
Assessed from the short form-8 instrument; scale 0 - 100, higher is more favorable quality of life
|
24 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KPSC IRB#10106M
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Steno Diabetes Center CopenhagenNot yet recruitingDiabetes | Diabetes Type 1 | Diabetes Type 2 | Digital Health | Diabetes Care | Remote Patient MonitoringDenmark
Clinical Trials on Telephone-based motivational interviews
-
Hospital Universitari Vall d'Hebron Research InstituteDepartment of Health, Generalitat de Catalunya; GETTEII ( Grupo Enfermero de...Completed
-
Inonu UniversityCompletedTrauma | Self Efficacy | ChildbirthTurkey
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Ovarian CancerUnited States
-
Amasya UniversityNot yet recruitingCancer | Health Behavior | Procrastination
-
Pamukkale UniversityCompletedSchizophrenia | Motivational InterviewsTurkey
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)UnknownAdvanced CancersUnited States
-
ElsanNot yet recruiting
-
University of Split, School of MedicineRecruitingObstructive Sleep Apnea (OSA)Croatia
-
Ohio University College of Osteopathic MedicineCompleted
-
Ankara Yildirim Beyazıt UniversityCompletedApgar Score | Behavior Change | Self-Efficacy for Decision Making | Models, Theoretical | Maternal and Neonatal OutcomesTurkey (Türkiye)